XML 61 R43.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables) | 12 Months Ended
--- | ---
Mar. 30, 2024
Segment Reporting [Abstract] |
Selected Information by Business Segment |
(In thousands) | 2024 |  | 2023 |  | 2022
Net revenues |  |  |  |  |
Plasma | $ | 565,399 |  |  | $ | 500,489 |  |  | $ | 351,945 |
Blood Center | 278,959 |  |  | 289,365 |  |  | 294,541 |
Hospital | 445,982 |  |  | 378,206 |  |  | 321,580 |
Net revenues by business unit | 1,290,340 |  |  | 1,168,060 |  |  | 968,066 |
Service (1) | 21,631 |  |  | 21,424 |  |  | 20,811 |
Effect of exchange rates | (2,916) |  |  | (20,824) |  |  | 4,319 |
Total net revenues | $ | 1,309,055 |  |  | $ | 1,168,660 |  |  | $ | 993,196 |
(1) Reflects revenue for service, maintenance and parts. |  |  |  |  |
(In thousands) | 2024 |  | 2023 |  | 2022
Segment operating income |  |  |  |  |
Plasma | $ | 309,791 |  |  | $ | 278,580 |  |  | $ | 183,131 |
Blood Center | 109,556 |  |  | 132,107 |  |  | 136,691 |
Hospital | 184,177 |  |  | 154,416 |  |  | 129,783 |
Segment operating income | 603,524 |  |  | 565,103 |  |  | 449,605 |
Corporate expenses (1) | (325,016) |  |  | (355,089) |  |  | (281,476) |
Effect of exchange rates | (1,971) |  |  | 8,419 |  |  | 18,993 |
Amortization of acquired intangible assets | (32,031) |  |  | (32,640) |  |  | (47,414) |
Amortization of fair value inventory step-up | (3,347) |  |  | — |  |  | — |
Integration and transaction costs | (11,249) |  |  | 411 |  |  | (21,604) |
Restructuring costs | (14,089) |  |  | (657) |  |  | (4,230) |
Restructuring related costs | (9,499) |  |  | (10,892) |  |  | (24,594) |
Digital transformation costs | (15,667) |  |  | (4,536) |  |  | — |
Write downs of certain in-process intangible assets and PCS2 related charges | (5,095) |  |  | 616 |  |  | (5,732) |
MDR and IVDR costs | (5,588) |  |  | (9,854) |  |  | (11,033) |
Litigation-related charges | (6,670) |  |  | (5,230) |  |  | (1,368) |
Impairment of intangible assets | (10,419) |  |  | — |  |  | — |
Gains on divestiture and sale of assets | 2,000 |  |  | 382 |  |  | 9,603 |
Operating income | $ | 164,883 |  |  | $ | 156,033 |  |  | $ | 80,750 |
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.
Net revenues by business unit are as follows:
(In thousands) | 2024 |  | 2023 |  | 2022
| Plasma | $ | 565,944 |  |  | $ | 496,923 |  |  | $ | 351,347 |
| Apheresis | 204,086 |  |  | 200,546 |  |  | 221,878 |
| Whole Blood | 72,058 |  |  | 79,416 |  |  | 76,634 |
| Blood Center | 276,144 |  |  | 279,962 |  |  | 298,512 |
| Interventional Technologies | 174,285 |  |  | 126,717 |  |  | 93,827 |
| Hemostasis Management | 159,139 |  |  | 138,854 |  |  | 127,379 |
| Other | 111,938 |  |  | 106,160 |  |  | 101,598 |
| Hospital | 445,362 |  |  | 371,731 |  |  | 322,804 |
Net business unit revenues | 1,287,450 |  |  | 1,148,616 |  |  | 972,663 |
| Service | 21,605 |  |  | 20,044 |  |  | 20,533 |
Total net revenues | $ | 1,309,055 |  |  | $ | 1,168,660 |  |  | $ | 993,196 |
(In thousands) | 2024 |  | 2023 |  | 2022
Depreciation and amortization |  |  |  |  |
Plasma | $ | 45,712 |  |  | $ | 41,612 |  |  | $ | 28,314 |
Blood Center | 13,391 |  |  | 13,927 |  |  | 32,489 |
Hospital | 38,112 |  |  | 37,768 |  |  | 36,944 |
Total depreciation and amortization (excluding impairment charges) | $ | 97,215 |  |  | $ | 93,307 |  |  | $ | 97,747 |
(In thousands) | March 30, 2024 |  | April 1, 2023 |  |
Long-lived assets(1) |  |  |  |  |
Plasma | $ | 211,121 |  |  | $ | 202,075 |  |  |
Blood Center | 54,262 |  |  | 68,395 |  |  |
Hospital | 45,979 |  |  | 40,415 |  |  |
Total long-lived assets | $ | 311,362 |  |  | $ | 310,885 |  |  |
(1) Long-lived assets are comprised of property, plant and equipment.
Selected information by operating regions is presented below:
(In thousands) | March 30, 2024 |  | April 1, 2023 |  |
Long-lived assets(1) |  |  |  |  |
United States | $ | 246,473 |  |  | $ | 251,812 |  |  |
Japan | 1,597 |  |  | 997 |  |  |
Europe | 15,310 |  |  | 14,587 |  |  |
Rest of Asia | 26,728 |  |  | 26,263 |  |  |
Other | 21,254 |  |  | 17,226 |  |  |
Total long-lived assets | $ | 311,362 |  |  | $ | 310,885 |  |  |
(1) Long-lived assets are comprised of property, plant and equipment.
(In thousands) | 2024 |  | 2023 |  | 2022
Net revenues |  |  |  |  |
United States | $ | 970,007 |  |  | $ | 842,897 |  |  | $ | 639,322 |
Japan | 58,087 |  |  | 61,295 |  |  | 75,562 |
Europe | 160,142 |  |  | 156,680 |  |  | 163,520 |
Rest of Asia | 107,536 |  |  | 104,135 |  |  | 110,802 |
Other | 13,283 |  |  | 3,653 |  |  | 3,990 |
Total net revenues | $ | 1,309,055 |  |  | $ | 1,168,660 |  |  | $ | 993,196 |

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration